Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Tn, Zabotina"'
Autor:
Ta, Bogush, Av, Konukhova, Ab, Ravcheeva, Tn, Zabotina, Z.G. Kadagidze, Ea, Bogush, Dv, Komov, Be, Polotskiĭ, Kk, Laktionov, Mi, Davydov
Publikováno v:
Europe PubMed Central
With an account of the literature data that platinum drugs react with many cellular targets, including ATP and proteins, the authors suggested that disturbance of the function of energy-dependent ABC-transporters (markers of multidrug resistance, MDR
Autor:
Baryshnikov AYu, Er, Polosukhina, Nn, Tupitsin, Nv, Gavrikova, Andreeva LYu, Tn, Zabotina, Sa, Mayakova, Vi, Kurmashov, Ab, Syrkin, Z.G. Kadagidze, Blochin DYu, Shishkin YuV
Publikováno v:
Europe PubMed Central
We analyzed CD95(Fas/APO-1) antigen expression on bone marrow blasts in 38 children with acute lymphoblastic leukemia (ALL) receiving a treatment in the Department of Leukaemias at the Cancer Research Center in 1987-1989 years (n = 22) and in 1994-19
Autor:
Er, Polosukhina, Sv, Kuznetsov, Np, Logcheva, Tn, Zabotina, Tenuta MR, Ad, Shirin, Gi, Kaletin, Ag, Turkina, Nv, Tsvetaeva, Shishkin IuV, Z.G. Kadagidze, Nd, Khoroshko, Ma, Volkova, Baryshnikov AIu
Publikováno v:
Europe PubMed Central
The expression of CD95(Fas/APO-1) antigen was studied on bone marrow cells of 19 MDS patients, peripheral blood blast cells of 15 acute myeloid leukemia (AML) patients, blast cells and granulocytes of 68 patients with chronic myeloid leukemia (CML)--
Autor:
Ay, Baryshnikov, Er, Polosukhina, Tn, Zabotina, Ni, Lazareva, Mi, Lukashina, Yv, Shishkin, Iv, Chinarjova, Tenuta MR, Is, Metelitsa, Z.G. Kadagidze
Publikováno v:
Europe PubMed Central
Using mAb ICO-160, we have studied Fas (APO-1/CD95) antigen expression on blood lymphocytes from healthy women, pregnant women and patients with chronic adnexitis, uterin myoma, ovarian cyst, ovarian and uterin cancer. In peripheral blood from health
Publikováno v:
Europe PubMed Central
A wide panel of monoclonal antibodies to differentiation antigens has been originally used to determine phenotype of peripheral blood lymphocytes in patients with prostatic cancer (PC). Patients with local PC exhibited marked lymphocytopenia existent
Publikováno v:
Europe PubMed Central
The immunologic phenotype of lymphocytes of young and middle-aged patients with breast cancer was identified using ICO monoclonal antibodies. The parameters were compared to that of healthy subjects of the corresponding age groups. Breast cancer pati
Autor:
Shishkin IuV, Np, Sediakhina, Tn, Zabotina, Sv, Kuznetsov, Ag, Turkina, Tn, Palkina, Er, Polosukhina, Ad, Shirin, Ma, Volkova, Ma, Frenkel, Nd, Khoroshko, Z.G. Kadagidze, Baryshnikov AIu
Publikováno v:
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::928e102f3ab67074f43d8e71f30b702e
http://europepmc.org/abstract/med/8998348
http://europepmc.org/abstract/med/8998348
Autor:
Nf, Mistakopulo, Vd, Shoshiashvili, Ai, Saltanov, Ne, Kushlinskiĭ, Av, Ivshina, Ai, Madzhuga, Lt, Liakina, Am, Ukrainets, Tn, Zabotina, Z.G. Kadagidze
Publikováno v:
Europe PubMed Central
The perioperative influence of leukinferon, indomethacin and their combination on the blood plasma level of thromboxane B2 (TxB2), platelet aggregation ability and humoral and cellular immunity has been assessed in 40 endometrial cancer patients. It
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::9770ea1bc6f521813c53ed8c9ff74a3a
http://europepmc.org/abstract/med/1416192
http://europepmc.org/abstract/med/1416192
Autor:
Korotaeva AA; Research Centre for Medical Genetics, Moscow, Russia., Borunova AA; N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia., Kuzevanova AY; Research Centre for Medical Genetics, Moscow, Russia., Zabotina TN; N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia., Alimov AA; Research Centre for Medical Genetics, Moscow, Russia.
Publikováno v:
Arkhiv patologii [Arkh Patol] 2023; Vol. 85 (6), pp. 76-83.
Autor:
Zabotina TN; N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Moscow, Russia. tatzabotina@yandex.ru., Korotkova OV; N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Moscow, Russia., Chertkova AI; N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Moscow, Russia., Zakharova EN; N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Moscow, Russia., Tabakov DV; N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Moscow, Russia., Dzhgamadze NT; N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Moscow, Russia., Savostikova MV; N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Moscow, Russia., Artamonova EV; N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Moscow, Russia., Khailenko VA; N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Moscow, Russia., Kovalenko EI; N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Moscow, Russia., Kadagidze ZG; N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Moscow, Russia.
Publikováno v:
Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2018 Dec; Vol. 166 (2), pp. 241-244. Date of Electronic Publication: 2018 Nov 28.